Clinical Trials Directory

Trials / Completed

CompletedNCT00035438

St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
60 (planned)
Sponsor
National Center for Complementary and Integrative Health (NCCIH) · NIH
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effectiveness of St. John's Wort as compared to placebo (an inactive substance) in the treatment of outpatients with obsessive compulsive disorder.

Detailed description

The objective of the proposed study is to assess the efficacy of the herbal St. John's Wort (SJW) in the treatment of symptoms of obsessive-compulsive disorder (OCD). The approach is to conduct a 12-week, randomized, double blind, placebo controlled, parallel group pilot trial with 30 subjects in each of two arms. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) will be the primary measure for evaluating OCD. An intention-to-treat analysis will be done to compare the two arms.

Conditions

Interventions

TypeNameDescription
DRUGSt. John's Wort

Timeline

Start date
2002-05-01
Completion
2003-09-01
First posted
2002-05-06
Last updated
2006-08-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00035438. Inclusion in this directory is not an endorsement.

St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder. (NCT00035438) · Clinical Trials Directory